GCG and obesity disorder: However, the physiological inhibitory control of GLP-1 and its accelerated inactivation by plasma dipeptidyl-peptidase 4 (DPP4) hyperactivity [22] suggests that the impaired secretion and/or activity of GLP-1 may be involved in the pathogenesis of obesity [23].